GLP-1 controls glucose metabolism and energy homeostasis by regulating food intake, islet hormone secretion and gastrointestinal motility via GLP-1 receptor (GLP-1R), enabling the development of GLP-1R agonists for the treatment of diabetes and obesity [15]. The gene discussed is GLP1R; the disease is obesity due to melanocortin 4 receptor deficiency.